In this work we are going to show results of intensive observation of adverse reactions of cyclosporine therapy during 18 months. The research was applied on 30 patients with kidney transplant. The medium time of kidney transplant survival was 9,7+/-2,3 years, with time span of 6 to 15 years. All the patients were subjects to several years' cyclosporine treatment, which was applied on a daily basis with a dosage of 2 to 5 mg/kg of body weight. The concentration of cyclosporine in blood was measured once a month. The concentration of cyclosporine in blood in 19 patients was in referent values of 122,50 nag/ml up to 280,50 nag/ml of blood. In 4 of the patients the concentration was heightened up to 370 to 538 nag/ml (X=766,37 nag/ml), and in ...
The long-term effect of cyclosporine A (CsA) in male Wistar rats with reduced renal mass was studied...
Abstract: Immunosuppressive drugs are now unavoidably used after the transplantation of liver, hear...
Background: There is little information about very long-term outcomes of kidney allograft recipients...
Background: Neurotoxicity side effects related to cyclosporine kinetics could lead to dysfunction of...
The use of cyclosporine long term after orthotopic liver transplantation has been analyzed in 73 adu...
Cyclosporine is a immunosuppressive agent used in solid organ and bone marrow transplantation worldw...
The use of cyclosporin in therapeutics is increasing. Unfortunately, cyclosporin has important detri...
The discovery and use of cyclosporine since its inception into clinical use in the late 1970s has pl...
Cyclosporine, a drug used in immunosuppression protocols for hematopoietic stem cell transplantation...
Nature and mediators of renal lesions in kidney transplant patients given cyclosporine for more than...
CYCLOSPORINE A (CsA) is a new immunosuppressive agent with unique properties; it suppresses humoral ...
This study analyzed early changes in trough blood cyclosporine concentrations and cyclosporine expos...
Cyclosporine, a drug used in immunosuppression protocols for hematopoietic stem cell transplantation...
Calcineurin inhibitors (CNIs) are typically used to prevent organ rejection and their use has signif...
International audienceCyclosporine is a widely used immunosuppressive agent to prevent rejection of ...
The long-term effect of cyclosporine A (CsA) in male Wistar rats with reduced renal mass was studied...
Abstract: Immunosuppressive drugs are now unavoidably used after the transplantation of liver, hear...
Background: There is little information about very long-term outcomes of kidney allograft recipients...
Background: Neurotoxicity side effects related to cyclosporine kinetics could lead to dysfunction of...
The use of cyclosporine long term after orthotopic liver transplantation has been analyzed in 73 adu...
Cyclosporine is a immunosuppressive agent used in solid organ and bone marrow transplantation worldw...
The use of cyclosporin in therapeutics is increasing. Unfortunately, cyclosporin has important detri...
The discovery and use of cyclosporine since its inception into clinical use in the late 1970s has pl...
Cyclosporine, a drug used in immunosuppression protocols for hematopoietic stem cell transplantation...
Nature and mediators of renal lesions in kidney transplant patients given cyclosporine for more than...
CYCLOSPORINE A (CsA) is a new immunosuppressive agent with unique properties; it suppresses humoral ...
This study analyzed early changes in trough blood cyclosporine concentrations and cyclosporine expos...
Cyclosporine, a drug used in immunosuppression protocols for hematopoietic stem cell transplantation...
Calcineurin inhibitors (CNIs) are typically used to prevent organ rejection and their use has signif...
International audienceCyclosporine is a widely used immunosuppressive agent to prevent rejection of ...
The long-term effect of cyclosporine A (CsA) in male Wistar rats with reduced renal mass was studied...
Abstract: Immunosuppressive drugs are now unavoidably used after the transplantation of liver, hear...
Background: There is little information about very long-term outcomes of kidney allograft recipients...